Olive Tree Capital

Olive Tree Capital is a Boston-based venture capital firm investing in groundbreaking technology and life sciences companies. The firm focuses on early-stage investments, including pre-seed, seed, and growth stages, with a particular emphasis on companies developing innovative solutions in technology and life sciences sectors. Their investment approach is guided by the Golden Rule, emphasizing ethical practices and meaningful partnerships. The firm operates without traditional deal structures, asset class limitations, or holding period constraints, allowing for flexible investments across various industries and geographies. This approach enables Olive Tree Capital to collaborate with entrepreneurs and businesses that contribute positively to society while pursuing profitability. The firm's portfolio includes companies such as Affini-T, Finless Foods, Inc., Alto Pharmacy, Anoma, Array Labs, Excision BioTherapeutics, Birch Biosciences, Boom Supersonic, Dren Bio, Inc., and Arternal. Olive Tree Capital's team comprises professionals with diverse backgrounds and expertise, including Nichola Eliovits, Mickael Chane-Du, Ashan Walpita, Joseph Lissak, and Isaac Btesh.

Entrepreneurial passion and commitment, Innovative business models, Positive societal and environmental impact, Scalable growth potential, Alignment with firm's ethical standards